RUSSO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 2.281
EU - Europa 1.400
AS - Asia 837
AF - Africa 240
SA - Sud America 238
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.015
Nazione #
US - Stati Uniti d'America 2.220
IT - Italia 589
SG - Singapore 458
CN - Cina 295
IE - Irlanda 253
BR - Brasile 224
CI - Costa d'Avorio 175
DE - Germania 141
FI - Finlandia 76
UA - Ucraina 68
CA - Canada 57
RU - Federazione Russa 55
AT - Austria 44
FR - Francia 41
SN - Senegal 41
NL - Olanda 24
GB - Regno Unito 23
VN - Vietnam 20
CZ - Repubblica Ceca 18
BE - Belgio 16
NG - Nigeria 14
SE - Svezia 14
AU - Australia 13
PT - Portogallo 8
TR - Turchia 7
UZ - Uzbekistan 7
AR - Argentina 6
CH - Svizzera 6
ES - Italia 6
IR - Iran 6
JP - Giappone 6
PK - Pakistan 6
IQ - Iraq 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
BG - Bulgaria 4
GR - Grecia 4
HU - Ungheria 4
VE - Venezuela 4
HK - Hong Kong 3
KG - Kirghizistan 3
LB - Libano 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
IN - India 2
NO - Norvegia 2
PL - Polonia 2
PY - Paraguay 2
TN - Tunisia 2
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
TW - Taiwan 1
Totale 5.015
Città #
Santa Clara 516
Chandler 435
Singapore 280
Dublin 244
Abidjan 175
Chicago 172
Catania 161
Houston 109
Boardman 105
Jacksonville 69
Civitanova Marche 63
Nuremberg 62
Cambridge 61
Lawrence 61
Andover 55
Ashburn 55
Helsinki 43
Dakar 41
Nanjing 38
Des Moines 34
Lappeenranta 32
Bremen 27
Vienna 27
Toronto 25
Rome 24
Wilmington 23
Hefei 22
Munich 22
Pozzallo 19
Dong Ket 18
Falls Church 18
Ottawa 17
Brno 16
Council Bluffs 16
Brussels 15
The Dalles 15
Abuja 14
Nanchang 14
Shanghai 14
Acireale 13
Saint Petersburg 13
Los Angeles 12
San Giovanni la Punta 11
Grafing 10
Tianjin 10
Beijing 9
Belo Horizonte 9
Mascalucia 9
Messina 8
Rio de Janeiro 8
San Mateo 8
Changsha 7
Hebei 7
L'Île-Saint-Denis 7
Naples 7
Padova 7
Seattle 7
São Paulo 7
Zhengzhou 7
Jiaxing 6
Ragusa 6
Amsterdam 5
Bari 5
Bologna 5
Espinho 5
Lanzhou 5
Manassas 5
Palermo 5
Porto Alegre 5
Redmond 5
Salvador 5
Turin 5
Arcadia 4
Berlin 4
Campinas 4
Florence 4
Fortaleza 4
Juiz de Fora 4
Maceió 4
Maletto 4
Melbourne 4
Moscow 4
Nissoria 4
Norwalk 4
Quintano 4
Redwood City 4
Reggio Calabria 4
Sciacca 4
Shenyang 4
Sydney 4
Taizhou 4
Tokyo 4
Bishkek 3
Delia 3
Edinburgh 3
Francofonte 3
Genoa 3
Guangzhou 3
Guarulhos 3
Hong Kong 3
Totale 3.504
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 210
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 106
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 106
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 103
In silico clinical trials: concepts and early adoptions 100
Computational modelling in melanoma for novel drug discovery 95
Agent based modeling of the immune system: NetLogo, a promising framework 90
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 89
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 89
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 89
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 88
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 85
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 85
Credibility of In Silico Trial Technologies - A Theoretical Framing 84
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 83
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 83
Boosting multiple sclerosis lesion segmentation through attention mechanism 82
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 81
Toward computational modelling on immune system function 80
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 79
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 78
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 76
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 75
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 75
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 73
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 73
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 72
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 71
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 71
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 70
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 67
In silico design of recombinant multi-epitope vaccine against influenza A virus 67
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 65
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 65
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 63
Computational models to predict disease course and treatment response in multiple sclerosis 62
Computational modelling approaches to vaccinology 61
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 61
Introducing scale factor adjustments on agent-based simulations of the immune system 61
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 61
PETAL: A Python tool for deep analysis of biological pathways 61
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 59
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 58
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 58
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 57
Computational immunogenetics 57
Generation of digital patients for the simulation of tuberculosis with UISS-TB 57
How can we accelerate COVID-19 vaccine discovery? 56
Modeling biology spanning different scales: An open challenge 55
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 54
The combination of artificial intelligence and systems biology for intelligent vaccine design 54
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 54
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 52
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 52
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 50
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 49
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 47
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 47
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 45
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 45
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 44
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 42
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 42
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 40
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 38
Quality by design tools reducing the gap from bench to bedside for nanomedicine 37
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 36
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 34
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 34
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 34
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 33
Modeling and Simulation of anakinra effects on severe COVID19 Patients 32
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 31
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 31
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 31
Text mining and word embedding for classification of decision making variables in breast cancer surgery 28
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 28
Generation of digital patients for the simulation of tuberculosis with UISS-TB 28
Toward computational modelling on immune system function 28
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 27
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 27
Evaluation of word embedding models to extract and predict surgical data in breast cancer 27
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 26
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 25
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 22
Model Credibility 20
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 20
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 16
Model Development 15
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 14
Verify: A toolbox for deterministic verification of computational models 10
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 7
Totale 5.248
Categoria #
all - tutte 19.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 0 0 0 0 28 29
2020/2021288 12 11 24 13 75 25 34 3 29 12 19 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.108 62 307 128 165 462 297 267 65 117 176 62 0
Totale 5.248